This webinar will discuss some of the major issues in the regulation of cosmetics. Upon completion of the session attendees will learn how regulators regulate cosmetics compared to other categories, fine line between cosmetics and drugs, and future directions for cosmetic regulations.
Furthermore, the regulation of cosmetics is often thought as “regulation light”, and a subject not taken seriously. Cosmetic regulations today are complex and becoming more so. Even more importantly, cosmetic science is spectacularly advanced and now borders on drug and medical device science.
Exacerbating the situation is that there is no harmonized global approach to regulation. Drugs and medical devices have, by comparison, far more consistent approaches, and receive a great deal of assistance from regulators in granting approvals. In many global markets, cosmetics simply arrive on store shelves and often the first intersection with a regulator is with a warning capable of threatening a company’s business.
This webinar will speak to some of the major issues in the science and regulation of cosmetics. While the focus will be on North America, there will be a general discussion on what regulatory framework this category deserves. What are the challenges facing the industry and regulators? Where is the line between cosmetics and drugs? How do we deal with the exciting and challenging innovations such as cosmetic active ingredients, medical devices and nutritional supplements for beauty? And finally, just how risky are today’s cosmetic products?
Why Should You Attend:
Nowhere in the world today do we have a united assessment of the risk proposed by cosmetics. There are often completely opposing views from consumers, scientists, NGOs, regulators and the companies who develop and market these products. Cosmetic labels scream of all of the nasty chemicals they do not contain. But who says they are nasty? Where’s the proof?Furthermore, the regulation of cosmetics is often thought as “regulation light”, and a subject not taken seriously. Cosmetic regulations today are complex and becoming more so. Even more importantly, cosmetic science is spectacularly advanced and now borders on drug and medical device science.
Exacerbating the situation is that there is no harmonized global approach to regulation. Drugs and medical devices have, by comparison, far more consistent approaches, and receive a great deal of assistance from regulators in granting approvals. In many global markets, cosmetics simply arrive on store shelves and often the first intersection with a regulator is with a warning capable of threatening a company’s business.
This webinar will speak to some of the major issues in the science and regulation of cosmetics. While the focus will be on North America, there will be a general discussion on what regulatory framework this category deserves. What are the challenges facing the industry and regulators? Where is the line between cosmetics and drugs? How do we deal with the exciting and challenging innovations such as cosmetic active ingredients, medical devices and nutritional supplements for beauty? And finally, just how risky are today’s cosmetic products?
Learning Objectives:
From the seminar you will learn:- The competing views of cosmetic risk
- How regulators regulate cosmetics compared to other categories
- The key issues regulating cosmetics
- The very fine line between cosmetics and drugs
- The roles of organizations influencing cosmetic regulations
- Future directions for cosmetic regulations
Areas Covered in the Webinar:
- Competing views of the risk of cosmetics
- Current approaches to the regulation of Cosmetics
- Issues with Cosmetic Regulation
- Organizations influencing regulations: governments, industry, NGOs
- Future predictions for Cosmetic Regulation
- How much risk do cosmetics pose?
Who Will Benefit:
- Regulatory affairs
- Research and Development
- Marketing personnel
- Manufacturers
- Brand owners
- Importers and Distributors
Course Provider
Rob Ross Fichtner,
